Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4Uterine Cervical Neoplasms 1Patient Compliance 1Pancreatic Neoplasms 1Head and Neck Neoplasms 1Fruquintinib 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

potassium oxonate 1Oxaliplatin 1Exercise 1Diet 1Capecitabine 1Acupuncture Points 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Patient Compliance × potassium oxonate × Clear all
NCT03448549 2020-03-06

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Peking University Cancer Hospital & Institute

Phase 3 Unknown
1,191 enrolled
Gastrointestinal

Patient Compliance, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡